Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Neurorehabilitation Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Neurorobotic Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Wearable Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Non-Invasive Stimulators
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Brain-Computer Interface
6.4.1 Market Trends
6.4.2 Market Forecast

7 Market Breakup by Application
7.1 Stroke
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Multiple Sclerosis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Parkinson’s Disease
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cerebral Palsy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cognitive Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Biometrics Ltd
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bioness Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bionik Laboratories Corp
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 BioXtreme Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Boston Scientific Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Ectron Ltd
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Ekso Bionics
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Hocoma AG (DIH International Limited)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Kinestica
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Kinova Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Medtronic plc
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Saebo Inc
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Tyromotion GmbH
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials